CN1266164C - 灵芝孢子粉多糖、生产方法和用途 - Google Patents
灵芝孢子粉多糖、生产方法和用途 Download PDFInfo
- Publication number
- CN1266164C CN1266164C CN 03141851 CN03141851A CN1266164C CN 1266164 C CN1266164 C CN 1266164C CN 03141851 CN03141851 CN 03141851 CN 03141851 A CN03141851 A CN 03141851A CN 1266164 C CN1266164 C CN 1266164C
- Authority
- CN
- China
- Prior art keywords
- ganoderma spore
- spore powder
- polysaccharide
- lucid ganoderma
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000222336 Ganoderma Species 0.000 title claims abstract description 67
- 239000000843 powder Substances 0.000 title claims abstract description 48
- 150000004676 glycans Chemical class 0.000 title claims abstract description 42
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 42
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 42
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000003960 organic solvent Substances 0.000 claims abstract description 8
- 238000001556 precipitation Methods 0.000 claims abstract description 8
- 239000012528 membrane Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 5
- 238000000502 dialysis Methods 0.000 claims description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- 230000036039 immunity Effects 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000004090 dissolution Methods 0.000 claims description 4
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 claims description 3
- 230000000259 anti-tumor effect Effects 0.000 claims description 3
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 238000004440 column chromatography Methods 0.000 abstract description 5
- 238000012360 testing method Methods 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 230000004071 biological effect Effects 0.000 abstract description 3
- 239000002244 precipitate Substances 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 239000000243 solution Substances 0.000 abstract 2
- 238000003809 water extraction Methods 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 238000007654 immersion Methods 0.000 abstract 1
- 230000036737 immune function Effects 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 239000010414 supernatant solution Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 239000008367 deionised water Substances 0.000 description 9
- 229910021641 deionized water Inorganic materials 0.000 description 9
- 239000012634 fragment Substances 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 238000001819 mass spectrum Methods 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 201000005202 lung cancer Diseases 0.000 description 3
- 208000020816 lung neoplasm Diseases 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 102000004420 Creatine Kinase Human genes 0.000 description 2
- 108010042126 Creatine kinase Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 244000000231 Sesamum indicum Species 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- -1 and is centrifugal Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 238000001641 gel filtration chromatography Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical class NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 201000002481 Myositis Diseases 0.000 description 1
- 206010068871 Myotonic dystrophy Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
峰 | 保留时间 | 面积 | 面积比 |
1 | 5.782 | 13301 | 0.33 |
2 | 7.758 | 634305 | 15.60 |
3 | 9.035 | 362204 | 8.91 |
4 | 9.560 | 212006 | 5.21 |
5 | 13.633 | 2844056 | 69.95 |
总计 | 4065873 | 100.00 |
峰 | 保留时间 | 面积 | 面积百分比 | 高度 | 高度百分比 |
1 | 7.739 | 385520 | 3.705 | 11402 | 5.536 |
2 | 13.774 | 9997512 | 96.081 | 194238 | 94.315 |
3 | 18.442 | 22225 | 0.214 | 307 | 0.149 |
总计 | 10405257 | 100.000 | 205947 | 100.000 |
峰 | 保留时间(min) | 类型 | 宽度(min) | 面积(pA*s) | 高度(pA) | 面积% |
1 | 14.517 | PB | 0.0567 | 153.78931 | 42.99859 | 11.39286 |
2 | 17.429 | BB | 0.0640 | 750.95807 | 162.18376 | 55.63168 |
3 | 17.721 | BB | 00574 | 85.68938 | 23.59284 | 6.34795 |
4 | 18.228 | BB | 0.0582 | 174.89603 | 47.18438 | 12.95646 |
5 | 21.125 | VB | 0.0558 | 184.54221 | 48.02483 | 13.67106 |
总计 | 1349.87498 | 323.98440 |
样品 | 剂量mg/kg | 给药方案 | 动物只数始/终 | 动物体重g始/终 | 瘤重g始/终 | 抑制率% |
LzPS | 200 | ip×10qd | 10/10 | 19.6/25.7 | 0.331±0.04*** | 62.89 |
LzPS | 100 | ip×10qd | 10/10 | 19.5/26.1 | 0.419±0.04*** | 53.03 |
阳性对照CTX | 30 | ip×7qd | 10/10 | 19.6/22.1 | 0.009±0.02*** | 98.99 |
阴性对照组 | 相应溶剂 | ip×10qd | 20/20 | 19.6/25.9 | 0.892±0.12 |
样品 | 剂量mg/kg | 给药方案 | 动物只数始/终 | 动物体重g始/终 | 瘤重g始/终 | 抑制率% |
LzPS | 200 | ip×10qd | 10/10 | 20.3/25.3 | 1.13±0.15*** | 57.36 |
LzPS | 100 | ip×10qd | 10/10 | 20.3/25.0 | 1.41±0.17*** | 46.79 |
阳性对照 | 30 | ip×7qd | 10/10 | 20.3/21.9 | 0.28±0.10*** | 89.43 |
CTX | ||||||
阴性对照组 | 相应溶剂 | ip×10qd | 20/20 | 20.1/25.5 | 2.65±0.26*** |
样品 | 剂量mg/kg | 给药方案 | 动物只数始/终 | #OD值X±SD | NK活性% | 与对参照组相比NK活性% |
LzPS | 200 | ip×10qd | 6/6 | 0.366±0.05*** | 55.20 | 29.21 |
LzPS | 100 | ip×10qd | 6/6 | 0.370±0.03*** | 54.47 | 28.05 |
阴性对照组 | 相应溶剂 | ip×10qd | 6/6 | 0.517±0.06 | 36.72 | 0.05 |
组别 | 剂量(mg/kg) | 动物只数始/终 | 体重(g)和血糖(mmol/L)测定值 | |||
第0天 | 第4天 | 第7天 | 第11天 | |||
正常组 | 10 | 174.0±7.43.94±0.54 | 186.5±8.22.93±0.48 | 206.9±13.73.51±0.32 | 220.5±22.24.34±0.70 | |
模型组 | 10 | 164.5±6.819.03±3.43 | 172.5±14.412.59±3.81 | 183.0±21.119.42±7.78 | 197.0±26.519.01±7.21 | |
LzPS | 100 | 10 | 167.5±13.617.96±3.59 | 181.0±16.113.65±4.38 | 192.5±23.514.88±4.90 | 197.0±28.415.24±6.13 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03141851 CN1266164C (zh) | 2003-07-25 | 2003-07-25 | 灵芝孢子粉多糖、生产方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03141851 CN1266164C (zh) | 2003-07-25 | 2003-07-25 | 灵芝孢子粉多糖、生产方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1513881A CN1513881A (zh) | 2004-07-21 |
CN1266164C true CN1266164C (zh) | 2006-07-26 |
Family
ID=34240345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03141851 Expired - Fee Related CN1266164C (zh) | 2003-07-25 | 2003-07-25 | 灵芝孢子粉多糖、生产方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1266164C (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102040748B (zh) * | 2009-10-16 | 2013-04-24 | 上海医药工业研究院 | 紫芝菌丝体抗肿瘤多糖组分gs-c、其制备方法和用途 |
CN103755828B (zh) * | 2014-01-16 | 2015-11-18 | 中国科学院上海有机化学研究所 | 灵芝孢子多糖、制备方法和应用 |
CN106309469A (zh) * | 2015-07-09 | 2017-01-11 | 山西国润制药有限公司 | 一种灵孢多糖注射液的制备工艺 |
CN106509905A (zh) * | 2016-11-03 | 2017-03-22 | 南京希元生物医药科技有限公司 | 一种破壁灵芝孢子粉多糖含片 |
CN108467438A (zh) * | 2018-02-01 | 2018-08-31 | 浙江寿仙谷医药股份有限公司 | 灵芝孢子粉壁多糖及其提取方法 |
CN113912751A (zh) * | 2021-12-01 | 2022-01-11 | 上海市农业科学院 | 一种富含半乳糖的灵芝孢子粉多糖及其制备方法 |
CN117186259A (zh) * | 2023-08-04 | 2023-12-08 | 深圳市岩代投资有限公司 | 一种分子结构明确的可消除化疗药毒副作用的多糖化合物 |
-
2003
- 2003-07-25 CN CN 03141851 patent/CN1266164C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1513881A (zh) | 2004-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108546306B (zh) | 一种蛹虫草培养基多糖及其分离纯化方法和用途 | |
CN100336833C (zh) | 土党参多糖、衍生物及其制备方法和应用 | |
CN100335505C (zh) | 用大孔吸附树脂制备樟芝多糖和樟芝三萜的方法及其产品 | |
CN103724445A (zh) | 灰树花多糖f2的制备方法及其降血糖功能 | |
CN109400741B (zh) | 一种灵芝孢子多糖的分离纯化方法 | |
CN1266164C (zh) | 灵芝孢子粉多糖、生产方法和用途 | |
CN108503724B (zh) | 蛹虫草培养基多糖及其分离纯化方法和应用 | |
CN103275237B (zh) | 一种茄枝多糖的制备方法及其应用 | |
CN1965894A (zh) | 一种具免疫活性的夏枯草多糖组合物及其制备方法和应用 | |
CN113717296B (zh) | 一种杜仲酸性多糖、提取方法及其在制备抗结肠癌药物中的应用 | |
CN107987179B (zh) | 一种低硫酸化岩藻半乳聚糖在制备免疫增强剂中的应用 | |
CN108641005B (zh) | 一种硫酸化紫锥菊多糖的制备方法及其应用 | |
CN110862463A (zh) | 具有生物活性的紫花苜蓿根部多糖及其硒化改性多糖的制备 | |
CN108641006B (zh) | 一种从蛹虫草培养基下脚料中提取并分离纯化多糖的方法 | |
CN1123577C (zh) | 海洋真菌炭团菌多糖及其提取方法和用途 | |
CN100417390C (zh) | 青蒿多糖有效部位及其制备方法和在制药中的应用 | |
CN1397566A (zh) | 抗肿瘤和免疫调节白术多糖、生产方法和用途 | |
EP0331821B1 (en) | Antiviral agent | |
CN103374078A (zh) | 紫芝液体深层发酵菌丝体均一多糖及其制备方法以及应用 | |
CN1205230C (zh) | 一种水溶性杂多糖及其制备方法和用途 | |
CN115141288B (zh) | 知母活性多糖、知母粗多糖及制备方法和应用 | |
CN111704679B (zh) | 一种猴头菌发酵菌丝体β-葡聚糖及其制备方法和应用 | |
CN115558035B (zh) | 一种具有免疫调节活性的天麻多糖 | |
CN116617247B (zh) | 一种有机超滤膜纯化分离制备的岗梅根多糖及其应用 | |
CN1238518C (zh) | 一种生产灰树花胞内多糖的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20040721 Assignee: Shanghai Green Valley Pharmaceutical Co., Ltd. Assignor: Institute of metal research|Chinese Academy of Sciences, Shanghai Institute of organic chemistry, Chinese Academy of Sciences Contract record no.: 2012310000166 Denomination of invention: Lucid ganoderma spore powder polysaccharide, production method and use Granted publication date: 20060726 License type: Exclusive License Record date: 20120917 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060726 Termination date: 20200725 |